Cargando…
Serum potassium as a predictor of adverse clinical outcomes in patients with chronic kidney disease: new risk equations using the UK clinical practice research datalink
BACKGROUND: To address a current paucity of European data, this study developed equations to predict risks of mortality, major adverse cardiac events (MACE) and renin angiotensin-aldosterone system inhibitor (RAASi) discontinuation using time-varying serum potassium and other covariates, in a UK coh...
Autores principales: | Furuland, Hans, McEwan, Phil, Evans, Marc, Linde, Cecilia, Ayoubkhani, Daniel, Bakhai, Ameet, Palaka, Eirini, Bennett, Hayley, Qin, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6106824/ https://www.ncbi.nlm.nih.gov/pubmed/30134846 http://dx.doi.org/10.1186/s12882-018-1007-1 |
Ejemplares similares
-
Serum potassium and clinical outcomes in heart failure patients: results of risk calculations in 21 334 patients in the UK
por: Linde, Cecilia, et al.
Publicado: (2019) -
The value of maintaining normokalaemia and enabling RAASi therapy in chronic kidney disease
por: Evans, Marc, et al.
Publicado: (2019) -
Real‐World Associations of Renin–Angiotensin–Aldosterone System Inhibitor Dose, Hyperkalemia, and Adverse Clinical Outcomes in a Cohort of Patients With New‐Onset Chronic Kidney Disease or Heart Failure in the United Kingdom
por: Linde, Cecilia, et al.
Publicado: (2019) -
The Impact of CKD Anaemia on Patients: Incidence, Risk Factors, and Clinical Outcomes—A Systematic Literature Review
por: Palaka, Eirini, et al.
Publicado: (2020) -
Assessment of Unmet Clinical Need in Type 2 Diabetic Patients on Conventional Therapy in the UK
por: Bennett, Hayley, et al.
Publicado: (2014)